- Home
- RDY vs AKAM Comparison
RDY vs AKAM Comparison
Compare RDY & AKAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- AKAM
- Stock Information
- Founded
- RDY 1984
- AKAM 1998
- Country
- RDY India
- AKAM United States
- Employees
- RDY N/A
- AKAM N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- AKAM Business Services
- Sector
- RDY Health Care
- AKAM Consumer Discretionary
- Exchange
- RDY Nasdaq
- AKAM Nasdaq
- Market Cap
- RDY 13.1B
- AKAM 15.3B
- IPO Year
- RDY N/A
- AKAM 1999
- Fundamental
- Price
- RDY $13.97
- AKAM $90.41
- Analyst Decision
- RDY Buy
- AKAM Buy
- Analyst Count
- RDY 1
- AKAM 18
- Target Price
- RDY $17.00
- AKAM $116.29
- AVG Volume (30 Days)
- RDY 770.6K
- AKAM 2.3M
- Earning Date
- RDY 11-05-2024
- AKAM 11-07-2024
- Dividend Yield
- RDY 4.04%
- AKAM N/A
- EPS Growth
- RDY 4.63
- AKAM 2.15
- EPS
- RDY 0.76
- AKAM 3.38
- Revenue
- RDY $3,579,112,656.00
- AKAM $3,966,246,000.00
- Revenue This Year
- RDY $13.39
- AKAM $6.82
- Revenue Next Year
- RDY $8.35
- AKAM $6.83
- P/E Ratio
- RDY $18.83
- AKAM $26.02
- Revenue Growth
- RDY 12.37
- AKAM 5.92
- 52 Week Low
- RDY $12.90
- AKAM $84.70
- 52 Week High
- RDY $16.89
- AKAM $129.17
- Technical
- Relative Strength Index (RSI)
- RDY 32.92
- AKAM 33.15
- Support Level
- RDY $13.97
- AKAM $84.70
- Resistance Level
- RDY $14.40
- AKAM $89.56
- Average True Range (ATR)
- RDY 0.27
- AKAM 2.48
- MACD
- RDY -0.04
- AKAM -0.87
- Stochastic Oscillator
- RDY 9.72
- AKAM 17.90
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About AKAM Akamai Technologies Inc.
Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.